Sulbutiamine

Commonly used for
EnergyFocus
Sulbutiamine raises brain thiamine levels more effectively than thiamine itself and modulates cholinergic, dopaminergic, and glutamatergic signaling; animal studies show improved object-recognition memory, but human efficacy for fatigue or cognition specifically is not well established -- this is not a treatment for a diagnosed thiamine deficiency, which needs direct medical management.
Form: Sulbutiamine (synthetic, fat-soluble dimer of thiamine/vitamin B1)
Typical dose studied: 400-600 mg/day (marketed dosing, not a well-validated clinical dose)
Timing: Morning or daytime -- can be mildly stimulating
Mostly preclinical support -- suggest short-term use given anecdotal reports of mood activation/tolerance with longer courses, and flag caution in bipolar disorder given its stimulating profile.
? Emerging / limited evidence
Avoid with: Bipolar disorder
Already taking it? Mostly preclinical evidence base -- reasonable to continue short-term if genuinely helpful, but be aware of anecdotal reports of tolerance and mood activation with longer use.
Bizot JC et al. (2005). Chronic Treatment With Sulbutiamine Improves Memory in an Object Recognition Task and Reduces Some Amnesic Effects of Dizocilpine. Progress in Neuro-Psychopharmacology & Biological Psychiatry.